StockData
VolitionRx Ltd logo

VolitionRx Ltd (VNRX) stock

VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.16−0.00 (-1.58%)

Close on Nov 20, 2026Market cap $2.21MP/E –Yield –

VolitionRx free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

VolitionRx's free cash flow for the twelve months ending Jun 30, 2026 was -$19.58M. For fiscal 2025 it was -$19.77M. The highest annual figure on record is -$1.69M in fiscal 2011.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$19.77M–
FY2024Dec 31, 2024-$26.17M–
FY2023Dec 31, 2023-$19.15M–
FY2022Dec 31, 2022-$16.85M–
FY2021Dec 31, 2021-$21.83M–
FY2020Dec 31, 2020-$18.41M–
FY2019Dec 31, 2019-$13.25M–
FY2018Dec 31, 2018-$14.43M–
FY2017Dec 31, 2017-$13.62M–
FY2016Dec 31, 2016-$9.28M–
FY2015Dec 31, 2015-$8.62M–
FY2014Dec 31, 2014-$4.44M–
FY2013Dec 31, 2013-$3.08M–
FY2012Dec 31, 2012-$2.41M–
FY2011Dec 31, 2011-$1.69M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$5.16M–
Q1 FY2026Mar 31, 2026-$5.29M–
Q4 FY2025Dec 31, 2025-$5.50M–
Q3 FY2025Sep 30, 2025-$3.63M–
Q2 FY2025Jun 30, 2025-$6.34M–
Q1 FY2025Mar 31, 2025-$4.30M–
Q4 FY2024Dec 31, 2024-$5.50M-189.7%
Q3 FY2024Sep 30, 2024-$5.52M–
Q2 FY2024Jun 30, 2024-$6.77M–
Q1 FY2024Mar 31, 2024-$8.37M–
Q4 FY2023Dec 31, 2023$6.14M–
Q3 FY2023Sep 30, 2023-$8.69M–
Q2 FY2023Jun 30, 2023-$7.65M–
Q1 FY2023Mar 31, 2023-$8.95M-356.6%
Q4 FY2022Dec 31, 2022-$6.38M–
Q3 FY2022Sep 30, 2022-$7.14M–
Q2 FY2022Jun 30, 2022-$6.81M–
Q1 FY2022Mar 31, 2022$3.49M–
Q4 FY2021Dec 31, 2021-$4.54M–
Q3 FY2021Sep 30, 2021-$5.02M–
Q2 FY2021Jun 30, 2021-$5.62M–
Q1 FY2021Mar 31, 2021-$6.65M–
Q4 FY2020Dec 31, 2020-$4.00M–
Q3 FY2020Sep 30, 2020-$4.58M–
Q2 FY2020Jun 30, 2020-$4.70M–
Q1 FY2020Mar 31, 2020-$5.13M–
Q4 FY2019Dec 31, 2019-$2.75M–
Q3 FY2019Sep 30, 2019-$4.31M–
Q2 FY2019Jun 30, 2019-$2.65M–
Q1 FY2019Mar 31, 2019-$3.54M–
Q4 FY2018Dec 31, 2018-$3.51M–
Q3 FY2018Sep 30, 2018-$4.56M–
Q2 FY2018Jun 30, 2018-$2.80M–
Q1 FY2018Mar 31, 2018-$3.57M–
Q4 FY2017Dec 31, 2017-$3.97M–
Q3 FY2017Sep 30, 2017-$2.93M–
Q2 FY2017Jun 30, 2017-$3.17M–
Q1 FY2017Mar 31, 2017-$3.54M–
Q4 FY2016Dec 31, 2016-$2.52M–
Q3 FY2016Sep 30, 2016-$2.14M–

More VolitionRx figures

See a number that looks wrong?